VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 336 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2017. The put-call ratio across all filers is 1.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $1,097,000 | -56.5% | 888,500 | +8.8% | 0.07% | -77.4% |
| Q3 2017 | $2,521,000 | -4.5% | 816,300 | -10.9% | 0.30% | +4.2% |
| Q2 2017 | $2,640,000 | -39.2% | 916,400 | +3.8% | 0.28% | -49.7% |
| Q1 2017 | $4,343,000 | -55.8% | 882,500 | -39.2% | 0.57% | -6.3% |
| Q4 2016 | $9,827,000 | +47.1% | 1,452,600 | -4.9% | 0.60% | +146.9% |
| Q3 2016 | $6,680,000 | -50.6% | 1,526,700 | -50.5% | 0.24% | -81.7% |
| Q2 2016 | $13,515,000 | -30.8% | 3,086,700 | +11.2% | 1.34% | -31.6% |
| Q1 2016 | $19,524,000 | -14.1% | 2,774,700 | +146.8% | 1.96% | +7.9% |
| Q4 2015 | $22,736,000 | -18.7% | 1,124,241 | +80.2% | 1.82% | +6.5% |
| Q3 2015 | $27,964,000 | +400.1% | 623,985 | +401.8% | 1.71% | +402.1% |
| Q2 2015 | $5,592,000 | -6.9% | 124,357 | -55.8% | 0.34% | -38.2% |
| Q1 2015 | $6,008,000 | -79.3% | 281,594 | -72.6% | 0.55% | -68.3% |
| Q4 2014 | $28,980,000 | +10.4% | 1,028,898 | -8.9% | 1.74% | +20.7% |
| Q3 2014 | $26,255,000 | +297.8% | 1,128,939 | +11311.5% | 1.44% | +406.7% |
| Q2 2014 | $6,600,000 | +230.0% | 9,893 | +632.8% | 0.28% | +51.9% |
| Q3 2013 | $2,000,000 | – | 1,350 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
| LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
| FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
| Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
| ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
| Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
| Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
| Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
| Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
| Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |